Cocrystal Pharma, Inc.COCPNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-9.82M
↑ 16% vs avg
Percentile
P47
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
$-11.71M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-9.82M | +40.5% |
| 2024 | $-16.49M | -11.6% |
| 2023 | $-14.78M | +31.3% |
| 2022 | $-21.51M | -68.4% |
| 2021 | $-12.77M | -26.8% |
| 2020 | $-10.07M | -489.6% |
| 2019 | $-1.71M | +79.5% |
| 2018 | $-8.32M | -19.8% |
| 2017 | $-6.94M | +52.8% |
| 2016 | $-14.71M | - |